Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/1/2020
SIETES contiene 92882 citas

 
 
 1 a 20 de 21 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Sheehan WJ, Mauger DT, Paul IM, Moy JN, Boehmer SJ, Szefler SJ, Fitzpatrick AM, Jackson DJ, Bacharier LB, Cabana MD, Covar R, Holguin F, Lemanske Jr RF, Martinez FD, Pongracic JA, Beigelman A, Baxi SN, Benson M, Blake K, Chmiel JF, Daines CL, Daines MO, Gaffin JM, Gentile DA, Gower WA, Israel E, Kumar HV, Lang JE, Lazarus SC, Lima JJ, Ly N, Marbin J, Morgan WJ, Myers RE, Olin JT, Peters SP, Raissy HH, Robison RG, Ross K, Sorkness CA, Thyne SM, Wechsler ME, Phipatanakul W, for the NIH/NHLBI AsthmaNet. Acetaminophen versus ibuprofen in young children with mild persistent asthma. N Engl J Med 2016;375:619-30. [Ref.ID 100711]
2. Cita con resumen
Bacharier LB, Guilbert TW, Mauger DT, Boehmer S, Beigelman A, Fitzpatrick AM, Jackson DJ, Baxi SN, Benson M, Burnham C-AD, Cabana M, Castro M, Chmiel JF, Covar R, Daines M, Gaffin JM, Gentile DA, Holguin F, Israel E, Kelly HW, Lazarus SC, Lemanske Jr RF, Meade K, Morgan W, Moy J, Olin T, Peters SP, Phipatanakul W, Pongracic JA, Raissy HH, Ross K, Sheehan WJ, Sorkness C, Szefler SJ, Teague WG, Thyne S, Martinez FD, for the National Heart Lung and Blood Institute's AsthmaNet. Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial. JAMA 2015;314:2034-44. [Ref.ID 99768]
3.Tiene citas relacionadas Cita con resumen
Kazani S, Israel E. Treatment with beta blockers in people with COPD. BMJ 2011;342:d2655. [Ref.ID 90940]
4. Cita con resumen
Wechsler ME, Kelley JM, Boyd IOE, Dutile S, Marigowda G, Kirsch I, Israel E, Kaptchuk TJ. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med 2011;365:119-26. [Ref.ID 90832]
5.Tiene citas relacionadas Cita con resumen
Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Craig T, Denlinger L, Engle LL, DiMango EA, Fahy JV, Israel E, Jarjour N, Kazani SD, Kraft M, Lazarus SC, Lemanske Jr RF, Lugogo N, Martin RJ, Meyers DA, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Walter MJ, Wechsler ME, Chinchilli VM, Bleecker ER, for the National Heart Lung and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363:1715-26. [Ref.ID 89555]
6.Tiene citas relacionadas Cita con resumen
Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske Jr RF, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E, for the National Heart Lung and Blood Institute's Asthma Clinical Research Network. Effect of beta2-adrenergic receptor polymorphism on response to longactinb beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 2009;374:1754-64. [Ref.ID 87230]
7.Tiene citas relacionadas Cita con resumen
Kraft M, Israel E, O'Connor GT. Treatment of mild persistent asthma. N Engl J Med 2007;356:2096-100. [Ref.ID 80047]
8.Tiene citas relacionadas Cita con resumen
Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fagy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske Jr RF, Liggett SB, Martin R, Mitra N, Peters S P, Silveerman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM, for the National Heart Lung and Blood Institute's Asthma Clinical Research Network. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505-12. [Ref.ID 71721]
9.Tiene citas relacionadas
Israel E, Fitzmaurice G, LeBoff MS. Bone loss and inhaled glucocorticoids. The authors reply. N Engl J Med 2002;346:534-5. [Ref.ID 60345]
10.Tiene citas relacionadas Cita con resumen
Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001;345:941-7. [Ref.ID 58702]
11.Tiene citas relacionadas Cita con resumen
Lemanske RF, Sorkness CA, Mauger EA, Lazarus SC, Boushey HA, Fahy JV, Drazen JM, Chinchilli VM, Craig T, Fish JE, Ford JG, Israel E, Kraft M, Martin RJ, Nachman S A, Peters S P, Spahn JD, Szefler SJ, for the Asthma Clinical Research Network of the National Heart Lung and Blood Institute. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol. A randomized controlled trial. JAMA 2001;285:2594-603. [Ref.ID 56916]
12.Tiene citas relacionadas Cita con resumen
Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF, Sorkness CA, Kraft M, Fish JE, Peters S P, Craig T, Drazen JM, Ford JG, Israel E, Martin RJ, Mauger EA, Nachman S A, Spahn JD, Szefler SJ, for the Asthma Clinical Research Network of the National Heart Lung and Blood Institute. Long-acting ß2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma. A randomized controlled trial. JAMA 2001;285:2583-93. [Ref.ID 56915]
13.Tiene citas relacionadas Cita con resumen
Israel E. Assessment of therapeutic index of inhaled steroids. Lancet 2000;356:527-8. [Ref.ID 52383]
14.Tiene citas relacionadas
Löfdahl C-G, Reiss T F, Leff JA, Israel E, Noonan M J, Finn AF, Seidenberg BC, Capizzi T, Kundu S, Godard P. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ 1999;319:87-90. [Ref.ID 45932]
15.
Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197-206. [Ref.ID 42408]
16.
O'Byrne PM, Israel E, Drazen JM. Antileukotrienes in the treatment of asthma. Ann Intern Med 1997;127:472-80. [Ref.ID 34830]
17. Cita con resumen
Drazen JM, Israel E, Boushey HA, Chinchilli VM, Fahy JV, Fish JE, Lazarus SC, Lemanske RF, Martin RJ, Peters S P, Sorkness C, Szefler SJ. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996;335:841-7. [Ref.ID 29096]
18. Cita con resumen
Israel E, Cohn J, Dubé L, Drazen JM, for the Zileuton Clinical Trial Group. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. JAMA 1996;275:931-6. [Ref.ID 26242]
19.Tiene citas relacionadas
Drazen JM, Israel E. Treating mild-asthma - when are inhaled steroids indicated?. N Engl J Med 1994;331:737-9. [Ref.ID 22648]
20.
Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Siegel SC, Tinkelman D, Murray JJ, Busse W, Segal A T, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Cohn J, Lanni C, Pearlman H, Karahalios P, Drazen JM. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993;119:1055-66. [Ref.ID 20428]
Seleccionar todas
 
 1 a 20 de 21 siguiente >>